CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENTYoshihiro Otani, Yeshavanth Banasavadi‐Siddegowda, Ashis Chowdhury et al.|Neuro-Oncology|2020Cited by 0
DDRE-26. INHIBITION OF PRMT5 SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENTYesh Banasavadi, Balveen Kaur, Sriya Namagiri et al.|Neuro-Oncology|2021Cited by 0